|

|
URINARY INCONTINENCE
IN FEMALES TREATED BY A NEW ADJUSTABLE PERI-URETHRAL BALLOON (ACT:
ADJUSTABLE CONTINENCE THERAPY)
|
|
| |
|
|
|
|
|
|
|
|
| |
|

|
Authors:
|

|
APARECIDA M. PACETTA;
MARCUS V. SADI; SILVIA S. CARRAMÃO; FLAVIO M.R. ALMEIDA
|
|
| |
|
|
|
|
|
|
|
|
| |
|
|

|
Institution:
|

|
Department of Gynecology
and Urology, Universidade de Santo Amaro, São Paulo, Brazil
|
|
| |
|
|
|
|
|
|
|
|
| |
|
|
|
| |
|
|
|
|
|
|
|
|
| |
|
|
|
|
| |
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
Introduction
and Objectives:
Balloons inserted around the urethra represent a new method for treating women
with stress urinary incontinence (SUI). The current balloons do not permit an
adjustment of the urethral compression necessary to promote continence and rely
solely on the surgeon's subjective impression. Usually more than a single procedure
is necessary to keep the patients dry. We present a new specially developed
adjustable device (ACT) used to correct female SUI.
Methods:
Nine patients with ages varying from 34 to 54 years (mean 42.2) and no previous
therapy for urinary incontinence underwent the procedure between Jul. 1999 and
Jan.2000. Six had type II and three type III SUI. All had video-urodynamic studies
done pre-operatively. The device is a small silicon balloon filled with 1-2cc
of diluted contrast, with a valve in its extremity. Through this valve, one
can percutaneously adjust the volume of the balloon post-operatively, if necessary.
One balloon was positioned on each side of the urethra close to the bladder
neck using specially developed introducers. The valvular segment of the device
was placed subcutaneously in the major labia. Patients were discharged on the
second PO day and kept on oral cefalosporins for 14 days.
Results:
All patients became totally dry after the procedure. The balloons were easily
positioned in the proximal urethra. One patient with no complications demanded
to have the device removed on the sixth post-operative week. Complications included
one bladder perforation during balloon implantation; distal migration of one
balloon and one balloon and valve extrusions. All complications were easily
corrected and after a mean follow up of 6 months, all patients remained dry
and apt.
Conclusions:
The ACT device promotes urinary continence in women. It is easily adjustable
and if necessary can be removed without difficulties. Complication rates were
similar to other previously reported peri-uretral devices and were easily manageable.
All patients remain totally dry on follow up.